ContributorsPublishersAdvertisers

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial

onclive.com
 2021-10-15

Cover picture for the articleExpert Riad Salem, MD, MBA, highlights key data from the phase 3 EPOCH study, which evaluated TheraSphere in patients with mCRC and liver metastases who failed first line chemotherapy. Riad Salem, MD, discusses data from the following presentation:. Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International,...

www.onclive.com

Comments / 0

Comments / 0